Paola, Italy

Giovanni Luca

This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Gh Care Inc.. Active years: 2014.

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Giovanni Luca: Innovator in Diabetes Treatment

Introduction

Giovanni Luca is a notable inventor based in Paola, Calabria, Italy. He has made significant contributions to the field of medical technology, particularly in the treatment of Type 1 diabetes mellitus. His innovative approach focuses on the use of Sertoli cells microencapsulated in hydrogel-based microcapsules.

Latest Patents

Giovanni Luca holds a patent for a microencapsulation process of Sertoli cells, which is aimed at preventing and treating Type 1 diabetes mellitus. The invention involves the production of microcapsules, preferably shaped as microspheres, that utilize Sertoli cells for therapeutic purposes. This patent represents a significant advancement in diabetes treatment methodologies.

Career Highlights

Throughout his career, Giovanni has worked with various companies, including Gh Care Inc. and Gh Care, Inc. D/b/a Altucell, Inc. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Giovanni has collaborated with notable professionals in his field, including Riccardo Calafiore and Mario Calvitti. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work.

Conclusion

Giovanni Luca's contributions to the field of diabetes treatment through his innovative patent demonstrate his commitment to improving healthcare solutions. His work with Sertoli cells and microencapsulation processes holds promise for future advancements in medical technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…